These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 9524092)
1. Survival following intensive chemotherapy with bone marrow reconstitution for children with recurrent intracranial ependymoma--a report of the Children's Cancer Group. Mason WP; Goldman S; Yates AJ; Boyett J; Li H; Finlay JL J Neurooncol; 1998 Apr; 37(2):135-43. PubMed ID: 9524092 [TBL] [Abstract][Full Text] [Related]
2. Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group. Finlay JL; Goldman S; Wong MC; Cairo M; Garvin J; August C; Cohen BH; Stanley P; Zimmerman RA; Bostrom B; Geyer JR; Harris RE; Sanders J; Yates AJ; Boyett JM; Packer RJ J Clin Oncol; 1996 Sep; 14(9):2495-503. PubMed ID: 8823328 [TBL] [Abstract][Full Text] [Related]
3. Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumors. Guruangan S; Dunkel IJ; Goldman S; Garvin JH; Rosenblum M; Boyett JM; Gardner S; Merchant TE; Gollamudi S; Finlay JL J Clin Oncol; 1998 Jul; 16(7):2486-93. PubMed ID: 9667268 [TBL] [Abstract][Full Text] [Related]
4. A high-dose busulfan-thiotepa combination followed by autologous bone marrow transplantation in childhood recurrent ependymoma. A phase-II study. Grill J; Kalifa C; Doz F; Schoepfer C; Sainte-Rose C; Couanet D; Terrier-Lacombe MJ; Valteau-Couanet D; Hartmann O Pediatr Neurosurg; 1996 Jul; 25(1):7-12. PubMed ID: 9055328 [TBL] [Abstract][Full Text] [Related]
5. Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. Mason WP; Grovas A; Halpern S; Dunkel IJ; Garvin J; Heller G; Rosenblum M; Gardner S; Lyden D; Sands S; Puccetti D; Lindsley K; Merchant TE; O'Malley B; Bayer L; Petriccione MM; Allen J; Finlay JL J Clin Oncol; 1998 Jan; 16(1):210-21. PubMed ID: 9440745 [TBL] [Abstract][Full Text] [Related]
6. High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors. Papadakis V; Dunkel IJ; Cramer LD; Kramer E; Papadopoulos E; Goldman S; Packer RJ; Willoughby M; Baker D; Garvin J; Strandjord S; Coccia P; Kaplan AM; Klemperer M; Finlay JL Bone Marrow Transplant; 2000 Jul; 26(2):153-60. PubMed ID: 10918425 [TBL] [Abstract][Full Text] [Related]
7. High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group. Dunkel IJ; Garvin JH; Goldman S; Ettinger LJ; Kaplan AM; Cairo M; Li H; Boyett JM; Finlay JL J Neurooncol; 1998 Mar; 37(1):67-73. PubMed ID: 9525840 [TBL] [Abstract][Full Text] [Related]
8. High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study. Mahoney DH; Strother D; Camitta B; Bowen T; Ghim T; Pick T; Wall D; Yu L; Shuster JJ; Friedman H J Clin Oncol; 1996 Feb; 14(2):382-8. PubMed ID: 8636747 [TBL] [Abstract][Full Text] [Related]
9. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue. Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857 [TBL] [Abstract][Full Text] [Related]
10. Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide. Chamberlain MC Pediatr Neurol; 2001 Feb; 24(2):117-21. PubMed ID: 11275460 [TBL] [Abstract][Full Text] [Related]
11. Tandem high-dose chemotherapy and autologous stem cell transplantation for anaplastic ependymoma in children younger than 3 years of age. Sung KW; Lim DH; Lee SH; Yoo KH; Koo HH; Kim JH; Suh YL; Joung YS; Shin HJ J Neurooncol; 2012 Apr; 107(2):335-42. PubMed ID: 22081297 [TBL] [Abstract][Full Text] [Related]
12. Regimen-related toxicity of myeloablative chemotherapy with BCNU, thiotepa, and etoposide followed by autologous stem cell rescue for children with newly diagnosed glioblastoma multiforme: report from the Children's Cancer Group. Grovas AC; Boyett JM; Lindsley K; Rosenblum M; Yates AJ; Finlay JL Med Pediatr Oncol; 1999 Aug; 33(2):83-7. PubMed ID: 10398181 [TBL] [Abstract][Full Text] [Related]
13. Etoposide-containing regimens with autologous bone marrow transplantation in children with malignant brain tumors. Busca A; Miniero R; Besenzon L; Cordero di Montezemolo L; Cenni M; Fagioli F; Sandri A; Vassallo E; Ricardi U; Madon E Childs Nerv Syst; 1997; 13(11-12):572-7. PubMed ID: 9454971 [TBL] [Abstract][Full Text] [Related]
14. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma. Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093 [TBL] [Abstract][Full Text] [Related]